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The aromatic diamidines represent a class of compounds with broad-spectrum antimicrobial activity;
however, their development is hindered by a lack of understanding of their mechanism of antimicrobial action.
DB75 [2,5-bis(4-amidinophenyl)furan] is a trypanocidal aromatic diamidine that was originally developed as a
structural analogue of the antitrypanosomal agent pentamidine. DB289, a novel orally active prodrug of DB75, is
undergoing phase IIb clinical trials for early-stage human African trypanosomiasis, Pneumocystis jiroveci carinii
pneumonia, and malaria. The purpose of this study was to investigate mechanisms of action of DB75 using
Saccharomyces cerevisiae as a model organism. The results of this investigation suggest that DB75 inhibits mito-
chondrial function. Yeast cells relying upon mitochondrial metabolism for energy production are especially sensitive
to DB75. DB75 localizes (by fluorescence) within the mitochondria of living yeast cells and collapses the mitochon-
drial membrane potential in isolated yeast mitochondria. Furthermore, addition of DB75 to yeast cells or isolated
rat liver mitochondria results in immediate uncoupling of oxidative phosphorylation and subsequent inhibition of
respiration. We conclude that the mitochondrion is a cellular target of DB75 in yeast cells and anticipate that the
results of this study will aid in the target-based design of new antimicrobial aromatic diamidines.
Human African trypanosomiasis (HAT) is a life-threatening
tropical disease caused by bloodstream infection with parasitic
protozoans of the subspecies Trypanosoma brucei rhodesiense
or T. brucei gambiense. HAT is resurgent and is currently
estimated to afflict up to 500,000 people (5). New and im-
proved therapies for HAT are urgently needed, since current
drugs, like pentamidine, are marked by serious shortcomings,
such as toxic side effects, difficulties in methods of administra-
tion, and lack of oral activity (4, 16).
DB75 [2,5-bis(4-amidinophenyl)furan] is an important aro-
matic diamidine that is active against Trypanosoma spp. (8, 9)
in vitro. DB289 [2,5-bis-(4-amidinophenyl)furan bis-O-methyl-
amidoxime] is the amidoxime prodrug of DB75 that is orally
active and metabolically converted to DB75. DB289 is cur-
rently undergoing phase IIb human clinical trials for treatment
of early-stage HAT, Pneumocystis jiroveci carinii pneumonia
(PCP), and malaria.
DB75 belongs to a class of compounds, known as the aro-
matic diamidines, which exert broad-spectrum antimicrobial
activity (reviewed in reference 3); however, the mechanism of
action of these compounds is poorly understood. DB75 is a
structural analogue of pentamidine [1,5-di(4-amidinophenoxy)
pentane] (Fig. 1), a clinically important aromatic diamidine
that is used to treat early-stage HAT, antimony-resistant leish-
maniasis, and AIDS-related PCP. Many modes of action have
been proposed for pentamidine. Studies in yeast have sug-
gested that pentamidine inhibits mitochondrial metabolism
(17, 26). Further investigation into the mechanism of action of
aromatic diamidines is needed.
The mechanism of action of DB75 is unknown and repre-
sents a research topic important to the target-based approach
to the design and development of novel trypanocidal aromatic
diamidines. The purpose of this study was to investigate mech-
anisms of antimicrobial action of DB75 using Saccharomyces
cerevisiae as a model organism. Yeasts are an attractive model,
given the ease of culturing them and performing appropriate
molecular techniques and the documented sensitivity of yeast
cells to pentamidine (17).
Here we report that DB75 concentrates in yeast mitochon-
dria and disrupts their function. Yeast cells growing in glycerol
medium, and therefore dependent on mitochondrial metabo-
lism, are particularly sensitive to this drug.
MATERIALS AND METHODS
Materials. Yeast extract-peptone-dextrose (YEPD) and yeast extract peptone
glycerol (YEPG) growth media were from Qbiogene, Inc. (Carlsbad, Calif.).
DB75 [2,5-bis(4-amidinophenyl)furan dihydrochloride] was obtained from David
Boykin at Georgia State University in Atlanta, and pentamidine isethionate
[1,5-di(4-amidinophenoxy)pentane isethionate] was prepared by LyphoMed, Inc.
(Melrose Park, Ill.). Zymolyase-20T and dithiothreitol were from Fisher Scien-
tific (Suwanee, Ga.). All other chemicals were from Sigma-Aldrich Co. (St.
Louis, Mo.), unless stated otherwise.
Yeast strains and culture conditions. S. cerevisiae strains D273-10B (ATCC
24657; MAT mal [rho]) and W303 (ATCC 201238; MAT leu2-3 leu2-112
trp1-1 ura3-1 his3-11 his3-15 ade2-1 can1-100) were grown either on YEPD agar
plates at 30°C or in YEPD or YEPG liquid cultures with aeration and gentle
shaking at 30°C.
Quantification of yeast growth inhibition. Using the methods of Ludewig et al.
(17) with minor modifications, three independent microdilution assays, each
conducted in triplicate, were performed to quantify the inhibition of yeast growth
by DB75 and pentamidine. Saturated cultures of S. cerevisiae D273-10B and
W303 cells, grown in either YEPD or YEPG, were diluted in fresh medium to
approximately 105 cells/ml. One hundred microliters of diluted cells was added to
each microtiter dish well containing 100 l of the appropriate concentration of
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test compound. Yeast cells were treated with 1:2 dilutions of either DB75 in the
concentration range of 0.130 through 530.5 M or pentamidine in the concen-
tration range of 1.051 M through 4.291 mM in dextrose medium and DB75 in
the concentration range of 0.0265 nM through 53.1 M or pentamidine in the
concentration range of 0.215 nM through 429.2 M in glycerol medium. Total
cell growth was assessed with a microplate reader to measure turbidity after
incubating the cells at 30°C with gentle shaking in sealed microtiter plates for
24 h if grown in YEPD or 48 h if grown in YEPG. Fifty percent inhibitory
concentrations (IC50s) were defined as the drug concentration that reduced the
cell population to 50% of that observed in nontreated controls, as determined
from plots of optical densities at 550 nm (OD550) versus log drug concentration,
[drug]. Statistics were determined with Microsoft Excel.
Fluorescence microscopy. The UV fluorescence patterns attained in live S.
cerevisiae D273-10B cells treated with DAPI (4,6-diamidino-2-phenylindole)
(Molecular Probes, Eugene, Oreg.) and DB75 were compared. DB75 excites at
365 nm and emits at 465 nm under UV light. Yeast cells grown overnight in
YEPD liquid medium at 30°C with gentle shaking were collected (3,000  g,
30°C, 5 min) with a Sorvall Legend RT centrifuge with a Heraeus 6445 rotor and
resuspended in 10 ml of sterile distilled water. Cells were treated with a final
concentration of 2.5-g/ml DAPI from a 1-mg/ml stock prepared in water and
were incubated at 30°C with gentle shaking for 30 min. Cells were collected
again, washed once with 1 phosphate-buffered saline and resuspended in 1
phosphate-buffered saline at 106 cells/ml. Yeast cells were treated with DB75 as
described below. Fluorescence images of wet mounts prepared from cells treated
with either DAPI or DB75 were captured with a 100 objective lens by using a
Nikon Microphot FXA microscope fitted with a Nikon UV2A cube for the trans-
mission of both blue and yellow fluorescent light. Fluorescent colocalization exper-
iments were conducted with cells treated simultaneously with DB75 and the mito-
chondrion-specific dye MitoFluor red 589 (Molecular Probes, Inc.), which has
excitation and emission peaks at 588 and 622 nm, respectively, and is viewed with
filters appropriate for the Texas red dye. Yeast cells at approximately 106 cells/ml in
5 ml of YEPD medium were exposed to 25 nM Mitofluor Red 589 alone, 1 M
DB75 alone, or 25 nM Mitofluor Red 589 plus 1 M DB75 for 1 h at room
temperature. UV fluorescence microscopy with a Nikon multiband triple-filter block
for DAPI-fluorescein isothiocyanate (FITC)-Texas red was performed with wet
mounts prepared after 1 h of exposure to the conditions described above. Images
were captured with a 100 objective lens and Scion Image software.
Measurement of mitochondrial membrane potential in isolated yeast mito-
chondria. S. cerevisiae D273-10B cells were grown in YEPD with considerable
aeration and gentle shaking at 30°C in overnight cultures to an OD660 of ap-
proximately 3.0. Cells were collected via centrifugation at 3,000  g for 5 min at
room temperature, using a Sorvall Legend RT centrifuge with a Heraeus 6445 rotor.
Mitochondrial membrane potential was measured in freshly prepared yeast mito-
chondria that were isolated from yeast spheroplasts via differential centrifugation, as
described by Yaffe in 1991 (25). The mitochondrial preparation was resuspended to
50 l/g of original cells in mitochondrial isolation buffer, composed of 0.6 M man-
nitol and 20 mM HEPES-KOH, pH 7.4. Total mitochondrial yield was determined
with the Bio-Rad detergent-compatible protein assay kit, by first dissolving 10 l of
sample in 1.0 ml of 0.6% sodium dodecyl sulfate at 95°C for 4 min. Changes in
mitochondrial membrane potential in isolated yeast mitochondria were investigated
spectrophotometrically with the membrane potential-sensitive dye safranin O, as
described by Akerman and Wikstrom (1). A Hewlett-Packard (HP) 8452A diode
array spectrophotometer and HP ChemStation software were used to record time-
dependent difference spectrums (  511 nm 	 533 nm) of 10 M safranin added
to 0.3-mg/ml yeast mitochondria in a glass cuvette of 1-cm light pass. Mitochondrial
preparations were made in freshly prepared medium containing 0.6 M mannitol, 2
mM phosphate-triethanolamine (TEA) (pH 6.8), 10 mM MgCl2, 0.5 mM EDTA, 5
mM Tris-succinate, and 1-mg/ml lipid-free bovine serum albumin. Changes in mi-
tochondrial membrane potential (
) in millivolts were estimated from a calibra-
tion curve correlating change in absorbance (  511 nm 	 533 nm) with 
 using
the Nernst equation [
  60 log (Kin)/(Kout)] as previously described (1). Every
mitochondrial preparation used contained intact, well-coupled mitochondria, as was
determined by immediate collapse of the mitochondrial membrane potential follow-
ing the addition of 2 M CCCP (carbonylcyanide m-chlorophenyl hydrazone). Each
experiment was conducted at room temperature, with all controls performed on the
same day, and was repeated at least three times.
Measurement of oxygen consumption. A YSI oxygen electrode (Yellow
Springs Instrument Co., Yellow Springs, Ohio) equipped with a water jacket
1.5-ml chamber (model 5775) containing a Teflon-coated magnetic stirring bar
was used to measure oxygen consumption of both whole yeast cells and isolated
rat liver mitochondria at 23°C and using a paper feed speed of 2 cm/min. In
assays using whole yeast cells, S. cerevisiae D273-10B cells were collected (3,000
 g, 30°C, 5 min) from cultures grown overnight in YEPG liquid medium at 30°C
with gentle shaking. Collected cells were suspended to 2  109 cells/ml in sterile
distilled water, and oxygen consumption was measured in 1.0  108 cells/ml. In
experiments using isolated rat liver mitochondria, mitochondria were isolated
from rat liver on the same day of the experiment, using differential centrifugation
as previously described (14). Liver was dissected from a male Sprague-Dawley rat
(approximately 250 g) that was starved overnight. The total protein concentra-
tion of mitochondrial preparation was determined by the biuret method (13), and
the sample was diluted to yield 50 mg/ml in sucrose-HEPES buffer, pH 7.4,
consisting of 0.25 M sucrose and 2 mM potassium HEPES. At the start of each
assay, the functionality of the mitochondrial preparation was assessed by deter-
mining the respiratory control ratio, calculated as the ratio of the slopes of
respiration in the absence of ADP and respiration maximally stimulated by ADP.
A respiratory control ratio between 5 and 8 indicated well-coupled, intact rat
liver mitochondria. Oxygen uptake of 1.0-mg/ml rat liver mitochondria was
measured in medium consisting of 0.2 M sucrose, 2 mM MgCl2, 1 mM EDTA, 5
mM Tris-succinate, and 10 mM potassium phosphate, pH 7.4. Respiration was
stimulated by the addition of 200 M ADP. The respiration rates before and
after addition of DB75 or pentamidine were measured with at least three inde-
pendent whole-yeast-cell or rat liver mitochondrial preparations, and the figures
show representative results.
RESULTS
Growth-inhibitory effects of DB75 and pentamidine in yeast
cells grown in dextrose and glycerol media. In order to deter-
mine if yeast cells are sensitive to DB75 and if yeast relying
upon mitochondrial respiratory function are more sensitive,
microdilution assays were performed to quantify the growth-
inhibitory effects of DB75 and pentamidine, using S. cerevisiae
strains D273-10B and W303 grown in media containing the
fermentable carbon source dextrose and the nonfermentable
carbon source glycerol (Table 1). Yeast cells grown in glycerol
medium were more sensitive to the growth-inhibitory effects of
DB75 (IC50 of 9.0  1.3 M [3.4  0.5 g/ml] for S. cerevisiae
D273-10B and 10.6  3.7 M [4.0  1.4 g/ml] for S. cerevisiae
W303) and pentamidine (IC50 of 133.0  75.1 M [6.2  3.5
g/ml] for S. cerevisiae D273-10B and 103.0  60.1 M [4.8 
2.8 g/ml] for S. cerevisiae W303) than yeast cells grown in
dextrose medium and treated with DB75 (IC50 of 265.3  0
M [100  0 g/ml] for S. cerevisiae D273-10B and 72.4  9.8
M [27.3  3.7 g/ml] for S. cerevisiae W303) and pentamidine
(IC50 of 3.167  0.403 mM [147.6  18.8 g/ml] for S. cerevi-
siae D273-10B and 1.421  0.255 mM [66.2  11.9 g/ml] for
S. cerevisiae W303) (Table 1). Complete inhibition of yeast
growth in dextrose medium was observed at 530.5 M DB75
or 4.292 mM pentamidine for D273-10B cells and 265.3 M
DB75 or 2.146 mM pentamidine for W303 cells. In contrast, yeast
cell growth in glycerol medium was completely inhibited by 26.5
FIG. 1. Structures of DB75 (A) and pentamidine (B).
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M DB75 or 429.2 M pentamidine for D273-10B cells and
53.1 M DB75 or 429.2 M pentamidine for W303 cells.
Fluorescent localization of DB75 within live yeast cells. The
intrinsic blue-emitting fluorescence of DB75 was used to char-
acterize its cellular distribution in live S. cerevisiae D273-10B
cells. DB75 is inherently fluorescent with an excitation (ex 
365 nm) and emission (em  465 nm) spectrum similar to that
of the DNA stain DAPI. The cellular localization of DAPI
within yeast cells (Fig. 2A, panel a) resembled the fluorescence
pattern observed in DB75-treated cells (Fig. 2A, panel b),
indicating that DB75 fluorescence localizes within the nucleus
and mitochondrion. To confirm that DB75 distributes within
the mitochondrion, live yeast cells were treated with the mito-
chondrion-specific dye MitoFluor Red 589 (Fig. 2B, panel a),
DB75 (Fig. 2B, panel b), or both MitoFluor Red 589 and DB75
(Fig. 2B, panel c). A pink fluorescence pattern was observed in
cells treated with both dyes and indicated the presence of Mit-
oFluor Red and DB75 within yeast mitochondria (Fig. 2B, panel
c). The blue fluorescence area in cells treated with both dyes
represents DB75 within the yeast nucleus (Fig. 2B, panel c).
Effects of DB75 and pentamidine on mitochondrial mem-
brane potential in isolated yeast mitochondria. We next inves-
tigated if DB75 was disrupting mitochondrial function by
determining if DB75 collapses mitochondrial membrane po-
tential. The membrane potential-sensitive dye safranin was
used to investigate changes in mitochondrial membrane poten-
tial in isolated yeast mitochondria treated with DB75 and pen-
tamidine. As expected, addition of safranin to the mitochon-
drial preparation in reaction medium resulted in an increase in
mitochondrial membrane potential (Fig. 3). Treatment of iso-
lated yeast mitochondria with DB75 and pentamidine caused a
rapid and dose-dependent collapse of the mitochondrial mem-
brane potential, with maximal effects observed at 300 M
DB75 or pentamidine (Fig. 3).
Effects of DB75 and pentamidine on respiration of whole
yeast cells. We next investigated if DB75 altered oxygen con-
sumption in whole yeast cells (Fig. 4). Treatment of yeast cells
with a concentration of at least 100 M DB75 resulted in
immediate stimulation of respiration, which lasted for approx-
imately 30 to 45 s (Fig. 4A). This stimulation of respiration was
subsequently followed by inhibition of respiration, with maxi-
mal inhibitory effects observed with 300 M DB75 (Fig. 4A).
In yeast cells treated with pentamidine, slight stimulation of
respiration was observed with a concentration of at least 100
M pentamidine for approximately 30 s (Fig. 4B). As noted in
DB75-treated cells, this transient period of stimulation was
followed by inhibition of respiration (Fig. 4B). The inhibitory
effects of DB75 and pentamidine on respiration were dose
dependent; maximal inhibition of respiration in yeast cells was
achieved with 300 M DB75 or pentamidine (Fig. 4A and B).
Compared to pentamidine, DB75 was a more potent inhibitor
of respiration in yeast cells (Fig. 4A and B).
Further oxygen consumption experiments were performed
to distinguish if DB75 prevented respiration by inhibiting the
mitochondrial respiratory chain, as occurs with citrinin (anti-
mycin) or cyanide, or by inhibiting the phosphorylation of ADP
by the mitochondrial ATP synthase, as is characteristic of oli-
gomycin. Respiratory chain inhibitors, but not phosphorylation
inhibitors, are capable of inhibiting respiration in the presence
of uncouplers of oxidative phosphorylation. DB75 inhibited
respiration of yeast cells in the presence of the uncoupler
CCCP, thus suggesting that DB75 is a respiratory chain inhib-
itor (Fig. 4C). Maximal inhibition of CCCP-stimulated respi-
ration occurred with the addition of 300 M DB75 to yeast
cells. DB75 is a more powerful inhibitor of the respiratory
chain than pentamidine, since the lowest concentration of
DB75 required to inhibit respiration in the presence of CCCP
was 100 M (data not shown), whereas 300 M pentamidine
(Fig. 4C) was the minimal concentration required to inhibit
CCCP-stimulated respiration.
Effects of DB75 and pentamidine on respiration of isolated
rat liver mitochondria. The transient stimulation of respiration
observed in yeast cells treated with DB75 and pentamidine
prompted us to investigate if these compounds uncouple oxi-
FIG. 2. Distribution of DB75 within live yeast cells. Comparison of
the fluorescent localization of DB75 and DAPI (A). UV fluorescent
microscopy images of wet mounts of S. cerevisiae D273-10B cells
treated for 1 h with either 7.1 M DAPI (a) or 1.0 M DB75 (b) were
captured. The cellular distributions of DAPI and DB75 are similar,
suggesting that DB75 accumulates within the nuclei and mitochondria
of yeast cells. Fluorescent localization of MitoFluor Red, DB75, and
MitoFluor Red plus DB75 (B). UV fluorescent microscopy images of
wet mounts of S. cerevisiae D273-10B cells treated for 1 h with 25 nM
MitoFluor Red 589 (a), 1.0 M DB75 (b), or 25 nM MitoFluor Red
589 plus 1.0 M DB75 (c) were captured. Fluorescent colocalization of
MitoFluor Red with DB75, as indicated by pink fluorescence, confirms
that DB75 enters yeast mitochondria.
TABLE 1. Inhibition of yeast growth by DB75 and pentamidine in





DB75 Pentamidine DB75 Pentamidine
D273-10B 265.3  0 3,167.4  403.4 9.0  1.3 133.0  75.1
W303 72.4  9.8 1,420.6  255.4 10.6  3.7 103.0  60.1
a IC50s were defined as the concentration of DB75 or pentamidine required to
reduce the yeast cell population to 50% of that in the untreated controls after
growing in YEPD or YEPG with gentle shaking at 30°C for 24 or 48 h, respectively.
The results are presented as mean IC50s and standard deviations of three indepen-
dent experiments. Data were analyzed with Student’s t test, and P  0.002 when
comparing IC50s attained in YEPD and YEPG for each strain and treatment.
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dative phosphorylation. Isolated rat liver mitochondria are
excellent systems to investigate drug-induced changes in oxi-
dative phosphorylation, since mammalian mitochondrial prep-
arations retain more tightly coupled respiratory functions than
mitochondria isolated from yeast cells. Therefore, isolated rat
liver mitochondria were used in oxygen consumption assays to
study the effects of DB75 and pentamidine on oxidative phos-
phorylation. All isolated rat liver mitochondrion preparations
used were well coupled, as indicated by attainment of respira-
tory control ratios within the range of 5.7 and 8.0. Addition of
100 or 200 M DB75 to isolated rat liver mitochondria in reaction
medium resulted in rapid stimulation of respiration, which lasted
for several minutes and eventually resulted in slight inhibition of
respiration (Fig. 5A). However, when rat liver mitochondria were
treated with higher concentrations of DB75 (300 or 400 M),
DB75 stimulated respiration for approximately 2 min and then
subsequently inhibited respiration (Fig. 5A). Treatment of iso-
lated rat liver mitochondria with 200, 300, or 400 M pentami-
dine resulted in slight stimulation of respiration, whereas negligi-
ble stimulation of respiration was observed with 100 M
pentamidine (Fig. 5B). The effects of DB75 and pentamidine on
ADP-stimulated respiration were also investigated in isolated rat
liver mitochondria (Fig. 5C). Both DB75 and pentamidine inhib-
ited ADP-dependent respiration; however, Fig. 5C indicates that
200 M pentamidine was a greater inhibitor of ADP-stimulated
respiration than 200 M DB75.
Additional experiments were performed to validate that DB75
was uncoupling oxidative phosphorylation of isolated rat liver
FIG. 3. Effect of DB75 (A) and pentamidine (B) on membrane potential in isolated yeast mitochondria. Time-dependent difference spectrums
(  511 nm 	 533 nm) of the indicator dye safranin were used to study membrane potential changes in 0.3-mg/ml mitochondria isolated from
S. cerevisiae D273-10B in reaction medium containing 0.6 M mannitol, 2 mM phosphate-TEA (pH 6.8), 10 mM MgCl2, 0.5 mM EDTA, 5 mM
Tris-succinate, and 1-mg/ml lipid-free bovine serum albumin. Changes in mitochondrial membrane potential () in millivolts were estimated from
a calibration curve correlating change in absorbance with , using the Nernst equation:   60 log [(Kin)/(K

out)]. Samples were treated with
10 M safranin and either (a) 50 M, (b) 100 M, (c) 200 M, or (d) 300 M DB75 or pentamidine as indicated. The figure shows representative
results of three independent experiments.
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mitochondria. Uncouplers are capable of reversing the inhibition
of respiration observed in oligomycin-treated mitochondria. The
addition of DB75 at a minimal concentration of 100 M (data not
shown) resulted in stimulation of respiration in the presence of
oligomycin, with maximal stimulatory effects observed at 300 M
DB75 (Fig. 5D). Treatment of isolated rat liver mitochondria with
DB75 resulted in a release of oligomycin-induced repression of
respiration that was transitory, since slight inhibition of respira-
tion was observed several minutes after adding 300 M DB75
(Fig. 5D). Treatment of rat liver mitochondria with 300 M
pentamidine resulted in negligible stimulation of respiration in
the presence of oligomycin (Fig. 5D).
DISCUSSION
The present work represents the first investigation into the
mode of antimicrobial activity of DB75, the active agent of an
orally active prodrug currently undergoing clinical trials for
treatment of early-stage HAT. Our data suggest that DB75
kills yeast cells by disrupting mitochondrial function. This con-
clusion is based upon the findings that yeast are more sensitive
to DB75 under growth conditions requiring mitochondrial
respiratory function rather than during fermentative growth
(Table 1), DB75 localizes (by fluorescence) within the mito-
chondria of living yeast cells (Fig. 2), DB75 collapses the mi-
tochondrial membrane potential in isolated yeast mitochon-
dria (Fig. 3), and DB75 alters mitochondrial respiration (Fig. 4
and 5). The cationic nature of DB75 and pentamidine (Fig. 1)
most likely facilitates the collapse in mitochondrial membrane
potential. Addition of DB75 to yeast cells (Fig. 4) or isolated
rat liver mitochondria (Fig. 5) results in immediate stimulation
of respiration and subsequent inhibition of respiration. Com-
pared to pentamidine, DB75 is a more potent inhibitor of
mitochondrial respiration of yeast cells and isolated rat liver
mitochondria (Fig. 4 and 5).
While there may be other possible alternatives explaining
the mechanism of action of DB75 and pentamidine in yeast
cells, disruption of mitochondrial function is most likely a
FIG. 4. Effect of DB75 and pentamidine on oxygen consumption in whole yeast cells. An oxygen polarograph was used to record oxygen
consumption of whole yeast cells in distilled water over time in the presence of 100, 200, or 300 M DB75 (A) or pentamidine (B) as indicated.
Effect of DB75 and pentamidine on respiration of whole yeast cells stimulated by CCCP (C). Oxygen consumption was recorded from whole yeast
cells in distilled water treated with 2 M CCCP alone, 2 M CCCP plus 300 M DB75, or 2 M CCCP plus 300 M pentamidine. The time of
drug addition is indicated by the arrows. The figure shows representative results of three independent experiments.
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major mechanism. For instance, the strong DNA-binding
properties of DB75 (2, 6, 15, 18, 23, 24) and pentamidine (12,
21) can potentially contribute to the mechanism of action.
Binding of DB75 and pentamidine to yeast mitochondrial
DNA is likely to occur, since DB75 and pentamidine are high-
affinity binders of AT-rich DNA sequences and the yeast mi-
tochondrial genome is 80% AT rich (11). Indeed, fluores-
cence microscopy indicated that DB75 distributed within the
DNA-containing organelles, namely the mitochondria and nu-
clei, of live yeast cells (Fig. 2). However, the DNA-binding
properties of DB75 are probably less important than its effects
on the mitochondrion in yeast cells, given that DB75 is a much
more potent inhibitor of yeast growth during nonfermentative
than fermentative growth.
The effect of DB75 on respiration was investigated in whole
yeast cells and in isolated rat liver mitochondria. Mitochon-
drial respiration accounted for the majority of the oxygen con-
sumed by whole yeast cells, since treatment of yeast cells with
the mitochondrial respiratory chain inhibitor citrinin resulted
in immediate and complete inhibition of respiration (data not
shown) and addition of the uncoupler CCCP (Fig. 4C) resulted
in instantaneous stimulation of respiration that continued until
all oxygen was consumed. Treatment of yeast cells with DB75
(Fig. 4A) results initially in a transient stimulation of respira-
tion that is followed by dose-dependent inhibition of respira-
tion. Rat liver mitochondrial preparations retain more tightly
coupled respiratory functions than mitochondria isolated from
yeast cells and therefore were used to confirm that the initial
stimulation of respiration was a result of DB75 uncoupling
oxidative phosphorylation (Fig. 5D). Our results are in agree-
ment with those attained in a previous study (19), in which the
authors concluded that pentamidine is an uncoupler of isolated
rat liver mitochondria. The subsequent inhibition of respira-
tion observed in DB75-treated yeast cells or isolated rat liver
mitochondria suggests that DB75 also inhibits respiratory
chain protein(s). The mechanism by which DB75 inhibits res-
piration within yeast mitochondria appears to involve inhibi-
tion of electron transfer within the mitochondrial respiratory
FIG. 5. Effect of DB75 and pentamidine on oxygen consumption in isolated rat liver mitochondria. Rat liver mitochondria (RLM) were added
at 1 mg/ml to reaction medium containing 0.2 M sucrose, 2 mM MgCl2, 1 mM EDTA, 5 mM Tris-succinate, and 10 mM potassium phosphate, pH
7.4. An oxygen polarograph was used to record oxygen consumption of RLM over time in the presence of 100, 200, 300, or 400 M DB75 (A) or
pentamidine (B) as indicated. Effect of DB75 and pentamidine on ADP-stimulated respiration (C). Arrows indicate the addition of 200 M ADP
and either 200 M DB75 or pentamidine to RLM in reaction medium. Effect of DB75 and pentamidine on oligomycin-repressed respiration (D).
Arrows indicate the addition of 200 M ADP, 1-g/ml oligomycin, and 300 M DB75 or pentamidine to RLM in reaction medium. The figure
shows representative results of three independent experiments.
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chain, rather than inhibition of ADP phosphorylation by the
mitochondrial ATPase (Fig. 4C).
In addition to being toxic to yeast mitochondria, our results
indicate that DB75 and pentamidine are harmful to isolated
rat liver mitochondria (Fig. 5). These results raise the issue of
the specificity of the antimicrobial action of DB75 and penta-
midine. Although it is unknown how DB75 and pentamidine
enter yeast cells, preferential uptake of these compounds by
parasite-specific transporters most likely contributes to speci-
ficity for killing trypanosomes by facilitating the intracellular
accumulation of DB75 and pentamidine to toxic concentra-
tions. Experimental evidence suggests that preferential uptake
of DB75 and pentamidine into trypanosomes is facilitated by
diamidine transporters found within the plasma membrane
that are absent in mammalian cells. For example, pentamidine
uptake in T. brucei brucei is mediated by the P2 amino-purine
transporter and two other trypanosome-specific plasma mem-
brane transporters (10). Transporter-mediated uptake of pen-
tamidine by trypanosomes results in the accumulation of pen-
tamidine to intracellular concentrations in the millimolar
range after treatment of trypanosomes with micromolar con-
centrations of pentamidine (7). Likewise, our group has found
that the P2 transporter and another plasma membrane trans-
porter appear to account for DB75 uptake in T. brucei brucei
(unpublished data). We will research if diamidine transporters
contribute to the mechanism of action of DB75 in trypanosomes.
Future investigations will determine if DB75 disrupts mito-
chondrial function in bloodstream-form T. brucei brucei. As
occurs in Saccharomyces (Fig. 3A), DB75 is expected to alter
mitochondrial function of bloodstream-form African trypano-
somes by collapsing mitochondrial membrane potential. Dissi-
pation of mitochondrial membrane potential represents a
likely mechanism of action, since maintenance of a membrane
potential is required for mitochondrial import of proteins in
bloodstream-form trypanosomes (22). However, unlike the
mechanism of action in yeast cells, DB75 is not expected to act
as an uncoupler or inhibit respiration of bloodstream-form
African trypanosomes, since the mitochondria of bloodstream-
form trypanosomes are incapable of oxidative phosphorylation
and energy production is primarily dependent upon glycolysis
during mammalian infection (22). Nevertheless, the mitochon-
dria of bloodstream-form trypanosomes represent potential
drug targets, since they are metabolically active and play im-
portant roles in regulating cellular calcium homeostasis (20)
and aid fatty acid metabolism (22).
Studies on the mechanism of action of DB75 are not only
relevant to the development of trypanocidal drugs. The orally
active prodrug of DB75, DB289, also demonstrates activity in
human clinical trials against PCP and malaria (unpublished
data). We therefore anticipate that our investigation into the
antimicrobial activity of DB75 in yeast cells will contribute
valuable information to a target-based approach for designing
novel antimicrobial aromatic diamidine compounds that target
the mitochondrion in pathogenic fungi and/or protozoans.
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